Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide. 2017

Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana

OBJECTIVE To characterize pharmacokinetics of cyclophosphamide and 4-hydoxycyclophosphamide (4-OHCP) in the plasma of healthy cats after oral, IV, and IP administration of cyclophosphamide. ANIMALS 6 healthy adult cats. PROCEDURES Cats were randomly assigned to receive cyclophosphamide (200 mg/m2) via each of 3 routes of administration (oral, IV, and IP); there was a 30-day washout period between successive treatments. Plasma samples were obtained at various time points for up to 8 hours after administration. Samples were treated with semicarbazide hydrochloride to trap the 4-OHCP in stable form, which allowed for cyclophosphamide and trapped 4-OHCP to be simultaneously measured by use of tandem mass spectrometry. Pharmacokinetic parameters were determined from drug concentration-versus-time data for both cyclophosphamide and 4-OHCP. RESULTS Cyclophosphamide was tolerated well regardless of route of administration. Pharmacokinetic parameters for 4-OHCP were similar after oral, IV, and IP administration. Area under the concentration-time curve for cyclophosphamide was lower after oral administration than after IV or IP administration. CONCLUSIONS AND CLINICAL RELEVANCE Cyclophosphamide can be administered interchangeably to cats as oral, IV, and IP formulations, which should provide benefits with regard to cost and ease of administration to certain feline patients.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
November 1994, Research in veterinary science,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
September 2016, Journal of veterinary internal medicine,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
July 2022, Journal of veterinary internal medicine,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
September 2016, American journal of veterinary research,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
October 2019, Journal of feline medicine and surgery,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
January 2011, Veterinary journal (London, England : 1997),
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
November 2014, Anti-cancer drugs,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
January 2011, Journal of veterinary internal medicine,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
September 1979, British journal of clinical pharmacology,
Katherine A Stroda, and Jacqueline D Murphy, and Ryan J Hansen, and Lisa Brownlee, and Elizabeth A Atencio, and Daniel L Gustafson, and Susan E Lana
February 2013, American journal of veterinary research,
Copied contents to your clipboard!